Publicación de Urgo Medical Iberia

It was wonderful to meet all partners of the CLAIMS consortium during the first face to face meeting in the beautiful Baveno area, where subsequently the ECF annual meeting took place focussing on 'Promoting and measuring recovery in MS', a topic very relevant to the CLAIMS project #CLAIMSProject #MultipleSclerosis #HealthcareInnovation #EUHealthResearch #IHIEurope

Welcome to the family, Embla 💚   Nicholas Syhler and Laust Wilster Axelsen are truly trailblazing founders on an important mission to tackle one of the most significant healthcare challenges - obesity 💥   GLP-1’s has proven to be extremely effective for weight loss and lately proven also important for risk of co-morbidity - this is transformative for the individual as well as societies across the globe. But medicine can’t stand alone - we need holistic coaching to ensure healthy weight loss and improve chances of long-term weight loss by changing habits and mindset 🧠 Embla is the perfect example of this, where on average 59 % less medicine is used but reaching same weight loss as the clinical studies 💪 🙌   Thanks for letting us join you, Nicholas Syhler and Laust Wilster Axelsen 🤩   Finally the BIGGEST shout out to the amazing coaches, doctors and nurses at Embla 💚 💛 💜 you rock!!   Seed Capital Denmark Niels Vejrup Carlsen Ulla Brockenhuus-Schack Christian Brøndum Lars Andersen Peter Egehoved Chris Porsgaard Anne Cathrine Wilhjelm Jakob Fuglede Nielsen Maria Engel Lemser Embla Crowberry Capital VentureFriends Founders Inovo.vc Børsen #digitalhealth #venturecapital #

(at that time) The inauguration of the PERMATA UNIMED Management for the 2023-2024 period was a valuable moment for me to be able to meet students who had a social spirit towards the environment in which they lived. Many lessons were learned during the period, continuing to participate in it during the period is an opportunity that cannot be repeated. PERMATA UNIMED #SahataSarohaIngotpodaIngothuta.

2024 marks 30 years of DSHEA and NutraIngredients-USA is excited to bring you this unmissable discussion! 💡What were the factors that kickstarted it's creation in 1994? 💡How has the Act developed over the 30 years? 💡What does the Industry want for the future? We will be uniting industry pioneers at the DSHEA at 30 Summit🤝Make sure you are in the room to hear from those who were actually there during the passage and implementation of DSHEA! https://bit.ly/-DSHEA #DSHEASummit

Maybe of interest to those of you interested in a basic introduction and update on “Engineering therapeutic antibodies” please see this presentation at the recent Workshop of the Paul-Martini-Stiftung https://lnkd.in/eRPKdW87

Presentations at MPN Congress and ASH Annual Meeting Reinforce Clinical Role of ropeginterferon alfa-2b-njft

The #PROMSInitiative Plenary Event is in less than two weeks!   In the magnificent venue of Baveno, a town located on the shores of the stunning Lake Maggiore, and preceding the start of the European Charcot Foundation Annual Meeting, the PROMS Plenary 2023 will feature international experts, patients and industry representatives under the title “Patient-Reported Outcomes: bridging the gap between clinical research and care”   Here are some highlights on the key agenda topics:   📍 Current gaps in detecting and monitoring MS unrecognized progression and the potential walkthrough offered by PRO measures; 📍 Barriers and enablers for PROMs’ implementation in clinical care and research; 📍 Digitally collected PRO measures: myths and opportunities; 📍 The future of the #PROMSinitiative: planning next steps to generate the maximum impacts on research, healthcare delivery, policy and regulation.   ➡ There is still time to register and attend: https://lnkd.in/du5kYiEb. If you wish to join online, click on the "PROMS Invitee (online)" option to watch the event remotely FOR FREE. If you wish to join the conference in person, please get in touch with us via direct message. #PatientEngagement #PROMs #LivingWithMS #MSConnections

Clinical trials NEED innovation. Is Advarra the one to guide the way? Gadi Saarony, CEO of Advarra, discusses the future of clinical research in our latest BioBreakthroughs with host Jared S. Taylor. Tune in to learn about Advarra's innovative approaches in clinical trials. #ClinicalResearch #AdvarraInnovation #sohcpodcasts #HealthcareInnovation Full length video in the comments!